Collection Patents [0/42] Periodical Articles [141/141] Conference Papers/Meeting Abstract [30/48] Siblings Su-Ying Wu [52/65] Others [58/60] Kak-Shan Shia [76/98] Yueh Andrew Yueh [29/32] Chung-Ming Chang [7/9] Jang-Yang Chang [18/18] Chun-Ping Chang [21/26] John Tsu-An Hsu [170/215] Shiow-Ju Lee [75/105] Jinq-Chyi Lee [23/24] Shu-Yu Lin [19/20] Ming-Shiu Hung [31/40] Shiow-Lin Pan(2009-2013) [16/17] Wen-Chieh Wang [13/15] Hung-Jung Wang [7/7] Chuan Shih(2014-2017) [35/39] Chun-Wei Tung [23/23] Ya-Hui Chi [21/25] Shau-Hua Ueng [22/24] Hong Zhuang [1/1] Shiu-Hwa Yeh [24/25] Teng-Kuang Yeh [133/152] Weir-Torn Jiaang [41/66] Yu-Sheng Chao(2002-2013) [120/212] Ching-Chuan Kuo [49/55] Lun Kelvin Tsou [28/29] Jyh-Haur Chern [31/52] Xin Chen(2002-2015) [53/67] Chiung-Tong Chen [180/212] Wan-Ching Yen [6/7] Ming-Chu Hsu(1997-2001) [3/10] Shu-Jung Chen(1998-2001) [3/11] Hua-Chien Chen(1997-2001) [9/9] Community Statistics Item counts issued in 3 years:13(5.63%) Items With Fulltext:171(74.03%) Download counts of the item Download times greater than 0:171(100.00%) Download times greater than 100:167(97.66%) Total Bitstream Download Counts:101477(1.89%) Last Update: 2024-11-28 13:45 Top Upload Loading... Top Download Loading... Recent Submissions DBPR116, a prodrug of BPRMU191, in ... Discovery of dual MER/AXL kinase in... Macrophage-mediated controlled rele... Targeting cathepsin S promotes acti... Discovery of novel AXL and MER inhi... Influence of ring strain on the for... A dual nociceptin and mu opioid rec... Development of furanopyrimidine-bas... A critical overview of current prog... Recent advances in total synthesis ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-50 of 231. (5 Page(s) Totally) 1 2 3 4 5 > >> View [10|25|50] records per page

Date	Title	Relation
2024-10-29	DBPR116, a prodrug of BPRMU191, in combination with naltrexone as a safer opioid analgesic than morphine via peripheral administration	Journal of Medicinal Chemistry. 2024 Oct 29;Article in Press.
2024-06-24	Macrophage-mediated controlled release of cysteine protease inhibitor from PLGA-PEG/hydroxyapatite microspheres for targeting cathepsin S in Alzheimer's disease	European Polymer Journal. 2024 Jun 24;214:Article number 113151.
2024-06-24	Discovery of dual MER/AXL kinase inhibitors as bifunctional small molecules for inhibiting tumor growth and enhancing tumor immune microenvironment	Journal of Medicinal Chemistry. 2024 Jun 24;Article in Press.
2024-05-09	Targeting cathepsin S promotes activation of OLF1-BDNF/TrkB axis to enhance cognitive function	Journal of Biomedical Science. 2024 May 09;31:Article number 46.
2023-11-03	Influence of ring strain on the formation of rearrangement vs cyclization isotwistane products in the acyl radical reaction of bicyclo[2.2.2]octanone	Organic Letters. 2023 Nov 3;25(43):7757-7762.
2023-10-05	A dual nociceptin and mu opioid receptor agonist exhibited robust antinociceptive effect with decreased side effects	European Journal of Medicinal Chemistry. 2023 Oct 05;258:Article number 115608.
2023-10	Discovery of novel AXL and MER inhibitors as potential anticancer and immune modulator drugs	Annals of Oncology. 2023 Oct;34(Suppl. 2):S214.
2023-02-07	Development of furanopyrimidine-based orally active third-generation EGFR inhibitors for the treatment of non-small cell lung cancer	Journal of Medicinal Chemistry. 2023 Feb 7;66(4):2566-2588.
2022-09-12	A critical overview of current progress for COVID-19: Development of vaccines, antiviral drugs, and therapeutic antibodies	Journal of Biomedical Science. 2022 Sep 12;29:Article number 68.
2022-08-09	Recent advances in total synthesis of natural products by masked ortho-benzoquinones	Journal of the Chinese Chemical Society. 2022 Aug 09;69(8):1210-1222.
2022-05-09	Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer	Journal of Biomedical Science. 2022 May 9;29:Article number 29.
2022-04-06	Identification of entry inhibitors against delta and omicron variants of SARS-CoV-2	International Journal of Molecular Sciences. 2022 Apr 6;23(7):Article number 4050.
2022-01-21	Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma	Journal of Biomedical Science. 2022 Jan 21;29:Article number 5.
2021-11-15	Design and synthesis of novel orally selective and type II pan-TRK inhibitors to overcome mutations by property-driven optimization	European Journal of Medicinal Chemistry. 2021 Nov 15;224:Article number 113673.
2021-10-14	Discovery of BPR1R024, an orally active and selective CSF1R inhibitor that exhibits antitumor and immunomodulatory activity in a murine colon tumor model	Journal of Medicinal Chemistry. 2021 Oct 14;64(19):14477-14497.
2021-07-16	Colloidal assemblies composed of polymeric micellar/emulsified systems integrate cancer therapy combining a tumor-associated antigen vaccine and chemotherapeutic regimens	Nanomaterials. 2021 Jul 16;11(7):Article number 1844.
2021-04-16	Development of a robust scale-up synthetic route for BPR1K871: A clinical candidate for the treatment of acute myeloid leukemia and solid tumors	Organic Process Research and Development. 2021 Apr 16;25(4):817-830.
2021-04-13	Chlorinated briarane diterpenoids from octocoral Briareum stechei (Kükenthal, 1908)	Tetrahedron Letters. 2021 Apr 13;69:Article number 152976.
2021-02-22	Mimicking H3 substrate arginine in the design of G9a lysine methyltransferase inhibitors for cancer therapy: A computational study for structure-based drug design	ACS Omega. 2021 Feb 22;6(9):6100-6111.
2021-01-31	Briarenols W-Z: Chlorine-containing polyoxygenated briaranes from octocoral briareum stechei (Kükenthal, 1908)	Marine Drugs. 2021 Jan 31;19(2):Article number 77.
2021-01-15	One-pot synthesis of dibenzo[b,f]oxepines and total synthesis of bauhinoxepin C	Journal of Organic Chemistry. 2021 Jan 15;86(2):1955-1963.
2021-01	Overcoming vincristine resistance in cancer: Computational design and discovery of piperine-inspired P-glycoprotein inhibitors	Chemical Biology and Drug Design. 2021 Jan;97(1):51-66.
2020-12-10	Tumor-agnostic inhibitors in oncology: A new phase for precision medicine	Journal of the Chinese Chemical Society. 2020 Dec 10;67(12):2216-2224.
2020-08	Design of a potent anticancer lead inspired by natural products from traditional Indian medicine	Journal of Biomolecular Structure and Dynamics. 2020 Aug;38(12):3563-3577.
2020-07	Design of drug-like hepsin inhibitors against prostate cancer and kidney stones	Acta Pharmaceutica Sinica B. 2020 Jul;10(7):1309-1320.
2020-05	Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitors	Bioorganic Chemistry. 2020 May;98:Article number 103689.
2020-03-01	A selective Aurora-A 5'-UTR siRNA inhibits tumor growth and metastasis	Cancer Letters. 2020 Mar 1;472:97-107.
2020-01	Identification of novel quinoline inhibitor for EHMT2/G9a through virtual screening	Biochimie. 2020 Jan;168:220-230.
2019-12	Lysosomal cysteine protease cathepsin S is involved in cancer cell motility by regulating store-operated Ca(2+) entry	Biochimica et Biophysica Acta. Molecular Cell Research. 2019 Dec;1866(12):Article number 118517.
2019-11-27	Discovery of a furanopyrimidine-based epidermal growth factor receptor inhibitor (DBPR112) as a clinical candidate for the treatment of non-small cell lung cancer	Journal of Medicinal Chemistry. 2019 Nov 27;62(22):10108-10123.
2019-10-08	Identification of two novel small compounds that inhibit liver cancer formation in zebrafish and analysis of their conjugation to nanodiamonds to further reduce toxicity	Advanced Therapeutics. 2019 Oct 8;2(12):Article number 1900105.
2019-10	Discovery of clinical candidate DBPR112, a furanopyrimidine-based epidermal growth factor receptor inhibitor for the treatment of non-small cell lung cancer	Annals of Oncology. 2019 Oct;30(Suppl. 5):789.
2019-10	The molecular mechanisms of EpCAM in regulating tumor progression and development of anti-EpCAM antibodies for colon cancer diagnosis and therapy	Annals of Oncology. 2019 Oct;30(Suppl. 5):786.
2019-07-03	Delineating the active site architecture of G9a lysine methyltransferase through substrate and inhibitor binding mode analysis: A molecular dynamics study	Journal of Biomolecular Structure and Dynamics. 2019 Jul 3;37(10):2581-2592.
2019-07	Dual Kit/Aur inhibitors as chemosensitizing agents for the treatment of melanoma: Design, synthesis, docking studies and functional investigation	Scientific Reports. 2019 Jul;9:Article number 9943.
2019-05-29	Insights for the design of protein lysine methyltransferase G9a inhibitors	Future Medicinal Chemistry. 2019 May 29;11(9):993-1014.
2018-11	Biomimetic Syntheses of (±)‐Isopalhinine A, (±)‐Palhinine A, and (±)‐Palhinine D	Angewandte Chemie. 2018 Nov;57(47):15572-15576.
2018-07	Clinical candidate DBPR112: A novel epidermal growth factor receptor inhibitor as a promising treatment for non-small cell lung cancer	Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 4789.
2018-07	Blockage of EGFR signaling repurposes tumor metabolism through suppression of glycolysis and Kreb cycle in head and neck cancer	Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 3944.
2018-05-10	Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition	European Journal of Medicinal Chemistry. 2018 May 10;151:533-545.
2018-04-25	Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors	European Journal of Medicinal Chemistry. 2018 Apr 25;150:491-505.
2018-01	Discovery and development of DBPR112 as a clinical candidate: A novel EGFR inhibitor for non-small cell lung cancer	Cancer Science. 2018 Jan;109(Suppl. 1):739.
2017-08-11	Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer	Scientific Reports. 2017 Aug 11;7:Article number 7972.
2017-07	Drug repurposing for chronic myeloid leukemia: In silico and in vitro investigation of DrugBank database for allosteric Bcr-Abl inhibitors	Journal of Biomolecular Structure and Dynamics. 2017 Jun;35(8):1833-1848.
2017-04	Discovery of BPR1K871-a quinazoline based multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation	Abstracts of Papers of the American Chemical Society. 2017 Apr;253:Meeting Abstract 482.
2017-04	Toward the total syntheses of natural products containing trans-decalin skeleton from masked o-benzoquinone	Abstracts of Papers of the American Chemical Society. 2017 Apr;253:Meeting Abstract 516.
2017-04	One-pot tandem oxidative dearomatization/ 4+3 cycloaddition: Masked o-benzoquinone with diaza-oxyallyl cation	Abstracts of Papers of the American Chemical Society. 2017 Apr;253:Meeting Abstract 185.
2016-12	Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation	Oncotarget. 2016 Dec;7(52):86239-86256.
2016-11-29	Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design	European Journal of Medicinal Chemistry. 2016 Nov 29;124:186-199.
2016-07	Therapeutic polymeric nanoparticles and the methods of making and using thereof: A patent evaluation of WO2015036792	Expert Opinion on Therapeutic Patents. 2016 Jul;26(7):751-755.

Showing items 1-50 of 231. (5 Page(s) Totally) 1 2 3 4 5 > >> View [10|25|50] records per page